This is a combined competition for VU and VUMC investigators. All investigators should follow these instructions.
Applications due Dec. 8
VU and VUMC may each nominate one candidate for the Mary Kay Ash Foundation Innovative/Translational Cancer Research Grant program for 2023. These awards provide $100,000 over two years to support innovative translational research for cancers affecting women, including but not limited to ovarian, uterine, breast, endometrial and/or cervical cancer.
The foundation seeks to fund innovative research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in the diagnosis, prognosis, prevention or treatment of cancer.
- Principal investigator must be a full-time assistant professor or higher (assistant, associate or full professor) and commit a minimum 5 percent effort.
- Staff scientists, postdoctoral trainees and instructors are NOT eligible.
- Up to one co-PI is permitted. Co-PI must meet the same eligibility requirements as PI (assistant Professor or higher).
- Postdoc contributors may be listed as co-investigator, but not co-PI.
- The maximum total budget is $100,000. Indirect costs may not exceed 15 percent of direct costs (e.g., direct costs ≤ $86,956, indirect costs ≤ $13,044).
- U.S. citizenship is not required.
Internal application process
Anyone interested in being considered as VU’s or VUMC’s nominee must submit the following to LSO@vanderbilt.edu by 5 p.m. on Dec. 8. Please combine your materials into a single PDF and reference the program name in the subject line of the email.
- Brief research plan including summary budget (2-page max.);
- Statement of support from department chair/center director; and
- NIH Biosketch or brief CV (5-page max.).
The chosen nominee will submit a full proposal to the foundation by the deadline of Feb. 1, 2023.
Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.